169 related articles for article (PubMed ID: 11086047)
1. Comparative ability of Qdm/Qa-1b, kb, and Db to protect class Ilow cells from NK-mediated lysis in vivo.
Jia SH; Kurepa Z; Bai A; Forman J
J Immunol; 2000 Dec; 165(11):6142-7. PubMed ID: 11086047
[TBL] [Abstract][Full Text] [Related]
2. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK lysis.
Gays F; Fraser KP; Toomey JA; Diamond AG; Millrain MM; Dyson PJ; Brooks CG
J Immunol; 2001 Feb; 166(3):1601-10. PubMed ID: 11160201
[TBL] [Abstract][Full Text] [Related]
4. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter.
Aldrich CJ; Waltrip R; Hermel E; Attaya M; Lindahl KF; Monaco JJ; Forman J
J Immunol; 1992 Dec; 149(12):3773-7. PubMed ID: 1460275
[TBL] [Abstract][Full Text] [Related]
5. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.
Kraft JR; Vance RE; Pohl J; Martin AM; Raulet DH; Jensen PE
J Exp Med; 2000 Sep; 192(5):613-24. PubMed ID: 10974028
[TBL] [Abstract][Full Text] [Related]
7. Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs.
Li L; Sullivan BA; Aldrich CJ; Soloski MJ; Forman J; Grandea AG; Jensen PE; Van Kaer L
J Immunol; 2004 Sep; 173(6):3707-15. PubMed ID: 15356116
[TBL] [Abstract][Full Text] [Related]
8. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
[TBL] [Abstract][Full Text] [Related]
9. Role of Qa-1(b)-binding receptors in the specificity of developing NK cells.
Salcedo M; Colucci F; Dyson PJ; Cotterill LA; Lemonnier FA; Kourilsky P; Di Santo JP; Ljunggren HG; Abastado JP
Eur J Immunol; 2000 Apr; 30(4):1094-101. PubMed ID: 10760798
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
[TBL] [Abstract][Full Text] [Related]
11. A Single-Domain TCR-like Antibody Selective for the Qa-1
Ghaffari S; Upchurch-Ange K; Gimlin S; Tripathi T; Sluijter M; Middelburg J; van Hall T; Weidanz J
J Immunol; 2022 May; 208(9):2246-2255. PubMed ID: 35418467
[TBL] [Abstract][Full Text] [Related]
12. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b.
DeCloux A; Woods AS; Cotter RJ; Soloski MJ; Forman J
J Immunol; 1997 Mar; 158(5):2183-91. PubMed ID: 9036964
[TBL] [Abstract][Full Text] [Related]
13. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
Tajima A; Tanaka T; Ebata T; Takeda K; Kawasaki A; Kelly JM; Darcy PK; Vance RE; Raulet DH; Kinoshita K; Okumura K; Smyth MJ; Yagita H
J Immunol; 2003 Aug; 171(4):1715-21. PubMed ID: 12902470
[TBL] [Abstract][Full Text] [Related]
14. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide.
Cotterill LA; Stauss HJ; Millrain MM; Pappin DJ; Rahman D; Canas B; Chandler P; Stackpoole A; Simpson E; Robinson PJ; Dyson PJ
Eur J Immunol; 1997 Sep; 27(9):2123-32. PubMed ID: 9341749
[TBL] [Abstract][Full Text] [Related]
15. Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells.
Chun T; Aldrich CJ; Baldeón ME; Kawczynski LV; Soloski MJ; Gaskins HR
Immunology; 1998 May; 94(1):64-71. PubMed ID: 9708188
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Qa-1 expression and determinant modification by an H-2D-linked gene, Qdm.
Aldrich CJ; Rodgers JR; Rich RR
Immunogenetics; 1988; 28(5):334-44. PubMed ID: 2459056
[TBL] [Abstract][Full Text] [Related]
17. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
18. Structure of the murine CD94-NKG2A receptor in complex with Qa-1
MacLachlan BJ; Sullivan LC; Brooks AG; Rossjohn J; Vivian JP
FEBS J; 2024 Apr; 291(7):1530-1544. PubMed ID: 38158698
[TBL] [Abstract][Full Text] [Related]
19. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.
Lu L; Ikizawa K; Hu D; Werneck MB; Wucherpfennig KW; Cantor H
Immunity; 2007 May; 26(5):593-604. PubMed ID: 17509909
[TBL] [Abstract][Full Text] [Related]
20. Evidence of functional Cd94 polymorphism in a free-living house mouse population.
Knutsen LE; Dissen E; Saether PC; Bjørnsen EG; Piálek J; Storset AK; Boysen P
Immunogenetics; 2019 Apr; 71(4):321-333. PubMed ID: 30535636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
